U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07633600) titled 'Phenotype Guided Vasoactive Medication During Kidney Transplantation' on March 27.
Brief Summary: The goal of this clinical trial is to learn if vasopressin improves the body's response to intravenous fluids during kidney transplantation in patients who have relaxed blood vessels. Researchers will compare the results of vasopressin to those who received calcium chloride.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Kidney Transplant
Fluid Management
Intervention:
DRUG: Phenotype-Guided Vasoactive Management
Recipients undergo intraoperative circulation phenotyping using pulse contour monitoring and flow-pres...